PMID: 1198246Nov 22, 1975Paper

The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
D P Myburgh

Abstract

The efficacy of lidoflazine was evaluated in 11 patients with chronic ischaemic heart disease. All patients had suffered one or more myocardial infarctions and all were bad risk patients with frequent ventricular ectopic beats. The patients were followed for periods of up to 23 months and 6-7 Holter tape recordings were performed at 4-weekly intervals. The frequency of ventricular ectopic beats decreased in 7 and remained unchanged in only 1 patient. One patient developed a recurrent acute myocardial infarction and 2 patients died, presumably of cardiogenic cause, but drug causation could not be excluded. It is concluded that the results justify further study of lidoflazine, not only as an anti-anginal but also as a ventricular antidysrhythmic agent.

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.